Kevin Williamson's most recent trade in Tenon Medical Inc was a trade of 1,041 Restricted Stock Units done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tenon Medical Inc | Kevin Williamson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 1,041 | 3,126 | - | - | Restricted Stock Units | |
| Tenon Medical Inc | Kevin Williamson | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 1,041 | 43,593 | - | 0 | Common Stock | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 58,987 | 61,070 | - | 0 | Common Stock | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 58,987 | 58,987 | - | - | Restricted Stock Units | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 01 Jan 2026 | 18,518 | 42,552 | - | 0.9 | 17,244 | Common Stock |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2025 | 117,974 | 117,974 | - | - | Restricted Stock Units | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2024 | 6,250 | 6,250 | - | - | Restricted Stock Units | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 2,083 | 2,083 | - | 0 | Common Stock | |
| Tenon Medical Inc | Kevin Williamson | Director, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2024 | 2,083 | 4,167 | - | - | Restricted Stock Units |